glp-1 liquid drops side effects GI Adverse of Glucagon-Like Peptide-1 Receptor Agonists Ozempic and GLP-1 Drugs: Risk

This is the body adjusting to GLP-1 and GIP receptor activation, particularly the slowed gastric emptying that GLP-1 produces

When you eat, nutrientsparticularly carbohydrates, fats, and proteinsstimulate these L-cells to release GLP-1 into the bloodstream

Healthcare professionals should provide comprehensive patient education at treatment initiation, including written instructions and, where possible, practical demonstration

GLP-1 receptor signaling in pancreatic alpha cells reduces glucagon secretion, further contributing to glucose lowering

Licensed options in the UK include orlistat (oral), semaglutide 2.4 mg (Wegovy, approved by NICE TA875 for eligible patients), and tirzepatide (Mounjaro for type 2 diabetes

12 Another limitation is the variability of the available literature, which includes different research designs (RCTs, cohorts, casecontrol studies)